Overview

Safety and Tolerability Study of Ragweed SLIT Tablets

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of several doses of ragweed pollen allergen extract administered as sublingual tablets in subjects with allergic rhinitis to ragweed.
Phase:
Phase 1
Details
Lead Sponsor:
Stallergenes
Stallergenes Greer
Collaborator:
Quintiles, Inc.